BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20926701)

  • 1. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
    Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
    Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease.
    Martínez-Martínez S; Frandoloso R; Gutiérrez-Martín CB; Lampreave F; García-Iglesias MJ; Pérez-Martínez C; Rodríguez-Ferri EF
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):61-7. PubMed ID: 21816489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.
    Huang X; Li Y; Fu Y; Ji Y; Lian K; Zheng H; Wei J; Cai X; Zhu Q
    Clin Vaccine Immunol; 2013 Jun; 20(6):912-9. PubMed ID: 23616407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
    Hau SJ; Eberle KC; Brockmeier SL
    Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproteomic analysis of the protective response obtained with subunit and commercial vaccines against Glässer's disease in pigs.
    Martínez-Martínez S; Frandoloso R; Rodríguez Ferri EF; Gil C; Hernández-Haro C; Yubero S; Gutiérrez Martín CB
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):235-47. PubMed ID: 23266097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic characterization of vaccines based on Haemophilus parasuis Nagasaki strain, OmpP2, OmpP5 and OmpD15, in colostrum-deprived pigs experimentally challenged with the same strain.
    Álvarez-Estrada Á; Martínez-Martínez S; Martín CG; García-Iglesias MJ; Pérez-Martínez C; Yubero-Delgado S; Guizzo JA; Frandoloso R; Rodríguez-Ferri EF
    Res Vet Sci; 2018 Aug; 119():292-301. PubMed ID: 30081339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
    Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
    BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in cellular immune response in colostrum-deprived pigs after immunization with subunit and commercial vaccines against Glässer's disease.
    Frandoloso R; Martínez-Martínez S; Yubero S; Rodríguez-Ferri EF; Gutiérrez-Martín CB
    Cell Immunol; 2012; 277(1-2):74-82. PubMed ID: 22721860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.
    Martín de la Fuente AJ; Rodríguez-Ferri EF; Frandoloso R; Martínez S; Tejerina F; Gutiérrez-Martín CB
    Res Vet Sci; 2009 Apr; 86(2):248-53. PubMed ID: 18783805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
    Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood cellular immune response in pigs immunized and challenged with Haemophilus parasuis.
    de la Fuente AJ; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Martínez-Martínez S; Frandoloso R; Tejerina F; Rodríguez-Ferri EF
    Res Vet Sci; 2009 Apr; 86(2):230-4. PubMed ID: 18783806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
    Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vaccine based on a mutant transferrin binding protein B of Haemophilus parasuis induces a strong T-helper 2 response and bacterial clearance after experimental infection.
    Martínez-Martínez S; Frandoloso R; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Álvarez-Estrada Á; Gutiérrez-Martín CB
    Vet Immunol Immunopathol; 2016 Oct; 179():18-25. PubMed ID: 27590421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different vaccine formulations on the development of Glässer's disease induced in pigs by experimental Haemophilus parasuis infection.
    Martín de la Fuente AJ; Gutiérrez Martín CB; Pérez Martínez C; García Iglesias MJ; Tejerina F; Rodríguez Ferri EF
    J Comp Pathol; 2009; 140(2-3):169-76. PubMed ID: 19135210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of efficacy obtained with a trivalent inactivated
    Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C
    Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5.
    Zhou M; Guo Y; Zhao J; Hu Q; Hu Y; Zhang A; Chen H; Jin M
    Vaccine; 2009 Aug; 27(38):5271-7. PubMed ID: 19576561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).
    Olvera A; Pina S; Pérez-Simó M; Aragón V; Segalés J; Bensaid A
    Vaccine; 2011 Mar; 29(15):2797-802. PubMed ID: 21320547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
    Li M; Li C; Song S; Kang H; Yang D; Li G
    Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.
    Barasuol BM; Guizzo JA; Fegan JE; Martínez-Martínez S; Rodríguez-Ferri EF; Gutiérrez-Martín CB; Kreutz LC; Schryvers AB; Frandoloso R
    Sci Rep; 2017 Sep; 7(1):10377. PubMed ID: 28871190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
    Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
    BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.